For the judges it is not one pill abortive and therefore minors can continue to ask the pharmacist, without the need for a prescription. The TAR’s decision is based on scientific documentation that precisely defines the five-day-later pill as not an abortive drug.
It was the Tar of Lazio to reject the request of some associations, including Pro Vita e Famiglia onlus and Family Day, which wanted to reintroduce the doctor’s request for girls who ask for the pill in the days following a relationship.
According to the judges they did not bring sufficient and decisive clinical data. The mentioned drug, EllaOne, ulipistral acetate, along with the older morning-after pill with Norlevo drug, can continue to be obtained without a prescription.
Last October, the drug agency, AIFA, opened the pharmacist to purchase the drug without a prescription even for minors. “It is a highly effective tool for emergency contraception for young women who have had unprotected intercourse, within 5 days of intercourse”, said the AIFA Director General, Nicola Magrini, “and it is also, to in my opinion, an ethical tool as it allows to avoid the critical moments that are usually borne only by girls ».
For the Medicines Agency it is “a turning point for the protection of the physical and psychological health of adolescents”. Mothers teenagers they are less likely to complete their studies and find a job and are more likely than others to raise their children alone and in disadvantaged contexts. From the first data on sales it does not seem that the possibility of having the pill even without a prescription has increased the number of requests.
In the appeal against Aifa the associations argued that there are no studies on the risks for minors and it was hypothesized a violation of law 194 with the use of a drug with “antinidatory effect and therefore of abortion practice”. On the other hand, these drugs do not interrupt an ongoing pregnancy, but only ovulation.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
